Impact of a Population Genomic Screening Program on Health Behaviors Related to Familial Hypercholesterolemia Risk Reduction.
Laney K JonesNan ChenDina A HassenMegan N BettsTracey KlingerDustin N HartzelDavid L VeenstraScott J SpencerSusan R SnyderJosh F PetersonVictoria SchliederAmy C SturmSamuel S GiddingMarc S WilliamsJing HaoPublished in: Circulation. Genomic and precision medicine (2022)
Despite disclosure of an FH risk variant, nonprescribing and nonadherence to lipid-lowering therapy remained high. However, when clinicians intensified medication regimens and participants adhered to medications, lipid levels decreased.